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The Validity of the Six Minute Walk Test in Determining VO2peak in Cancer
Survivors: A Pilot Study
Deandra Elcock
Mentor: Dan Shackelford, Ph.D., Rocky Mountain Cancer Rehabilitation Institute
Abstract: Peak oxygen consumption (VO2peak) is critical for developing and implementing an exercise
prescription to guide a cancer survivor’s rehabilitative exercise program, which will improve physiological and
psychological values in cancer survivors. Many clinicians choose a submaximal protocol, the 6 Minute Walk Test
(6MWT) to determine VO2peak. The University of Northern Colorado Cancer Rehabilitation Institute’s (UNCCRI)
treadmill protocol is cancer-specific and accurately determines VO2peak. PURPOSE: To determine the validity of
VO2peak obtained from the 6MWT compared to the VO2peak obtained by the UNCCRI treadmill protocol.
METHODS: 34 cancer survivors completed the UNCCRI treadmill protocol and the 6MWT in randomized order
one week apart. VO2peak derived from the four commonly used equations for the 6MWT were compared to VO2peak
obtained from the UNCCRI treadmill protocol. RESULTS: All four 6MWT’s equation mean differences
significantly underestimated VO2peak compared to the UNCCRI treadmill protocol (p <0.001). Cancer survivors
also exercised at a higher intensity executing the UNCCRI treadmill protocol. CONCLUSION: The 6MWT
significantly underestimates VO2peak, inhibits cancer survivors from training at a higher intensity level, and should
not be used in formulating an exercise prescription. Clinicians should utilize the UNCCRI treadmill protocol.
Keywords: cancer, rehabilitation, VO2peak

INTRODUCTION
Cancer is a collection of diseases in which
cells exhibit uncontrolled cell growth and
development; it is among one of the leading
causes of death in the world. In 2016 an estimated
1.7 million new cases of cancer will be diagnosed
in the United States and 595,690 people will
succumb to the disease; this translates to 1,630
Americans dying per day (American Cancer
Society, 2016). However, there are nearly 15.5
million cancer survivors living today, and the
number of cancer survivors will continue to
increase to 20 million by 2026 (National Cancer
Institute, 2016). Of those cancer survivors, many
will suffer from negative side effects from both
the cancer and cancer treatments.
Cancer requires long-term management and
there is an exponential need for exercised-based
rehabilitation interventions for cancer survivors
(Spence, Heesch, & Brown, 2010). Research has
affirmed that cancer rehabilitation programs, and
specifically the use of exercise prescriptions, have
been associated with prolonged survival and
combats the negative side effects tied to cancer
and cancer treatments (American Cancer Society,
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2016). Commonly used as a baseline for postrehabilitation comparisons, peak volume of
oxygen consumption (VO2peak) is used to
determine an individual’s overall fitness level and
health status. Stevens, Kirby, Buckworth, Devor,
and Hamlin (2007) utilized VO2peak to train
African American females with prehypertension.
Using cardiorespiratory fitness, the ability of the
body's circulatory and respiratory system to
deliver necessary nutrients to the rest of the body
during sustained exercise, Stevens et al. were able
to compare cardiorespiratory fitness pre and post
exercise intervention by training the females at
70% of their VO2peak (Stevens et al., 2007).
Likewise, VO2peak is used in developing and
administering individualized exercise
prescriptions within the cancer population, as well
as using percent of VO2peak to regulate intensity.
Training at a higher percent of VO2peak elicits a
greater intensity.
However, cancer rehabilitation is a growing
field with the absence of common practice in
cancer-specific standardized protocols. A
frequently used protocol utilized in determining
VO2peak is the Six Minute Walk Test (6MWT).
The 6MWT is infamous for underestimating
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VO2peak. Consequently, inaccurate uses of VO2peak
can be detrimental to exercise prescriptions due to
inhibiting a CS from training at an accurate
exercise intensity. By way of contrast, clinics such
as the University of Northern Colorado Cancer
Rehabilitation Institute (UNCCRI) utilize a
treadmill protocol, to obtain a more accurate
VO2peak used in exercise prescriptions. Training at
an accurate exercise intensity maximizes the
physiological benefits from exercised-based
prescription training. Therefore, the purpose of
this present study is to determine the validity of
VO2peak obtained from the 6MWT compared to
the VO2peak obtained by the UNCCRI treadmill
protocol in working with cancer survivors.
REVIEW OF LITERATURE
Side effects related to cancer and cancer
treatments include fatigue, depression, cachexia,
decreased quality of life (QOL), and most
commonly, cardiovascular diseases (Schneider,
Hsieh, Sprod, Carter, & Hayward; Shackelford et
al., 2015; Yusuf, Razeghi, Yeh, 2008). Due to
diminished cardiovascular capabilities, many
cancer survivors also have poor cardiorespiratory
function (Myers, O’Neil, Walsh, Hoffmeister,
Venzon, & Johnson, 2015). Common symptoms
of decreased cardiorespiratory capabilities
include wheezing, dyspnea, and shortness of
breath (Myers et al., 2005; Raber-Durlacher et
al., 2012; Sarna et al., 2004). Lacking the ability
to efficiently exchange gases between the heart
and lungs further hinders one’s cardiovascular
capabilities. Cardiorespiratory function and
fitness are as influential as the traditional risk
factors in cardiopulmonary disease, and is often
more strongly associated with mortality (Lee,
Artero, Sui, & Blair 2010). One approach to
examine cardiorespiratory function is to measure
chronic physical activity. By measuring chronic
physical activity, physicians can assess how
healthy an individual is based on their
cardiovascular and respiratory function and
efficiency. Clinicians have explored ways to
reverse side effects of cancer and cancer
treatments such as fatigue and cachexia, increase
aspects of cardiovascular capabilities, and
increase the QOL for cancer survivors. One way
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to increase a cancer survivor's QOL is through
exercise-based cancer rehabilitation programs.
Cancer rehabilitation encompasses many aspects,
all which seek to assist individuals who
experience, or are likely to experience disability,
to achieve and maintain optimal functioning
within the limits imposed by disease and its
treatment (Cromes, 1978; Handberg, Lomborg,
Nielsen, Oliffe, & Midtgaard, 2015). According
to the American Cancer Society (2016), the 5year survival rate for individuals diagnosed with
cancer from 2005-2011 was 69%, which has
increased from the 49% survival rate from 19751977. The increase survival rate can be attributed
to advanced treatments, earlier detection, and the
implementation of cancer rehabilitation programs
(Shackelford et al., 2015; Thijs et al., 2012).
The majority of cancer rehabilitation clinics,
such as UNCCRI, promotes exercise-based cancer
rehabilitation through prescriptive exercise.
UNCCRI utilizes numerous factors such as, but
not limited to: type of cancer, age, medication,
treatments, treatment related side-effects, and
cardiovascular related functions to create an
individualized exercise prescription to help
combat the negative side effects resulting from
cancer and cancer treatments.
Cancer rehabilitation is a rapidly emerging
and evolving medical field in both Europe and the
United States, largely because of increases in rates
of cancer survival (Stubblefield et al, 2013).
However, with the lack of foundation preceding
the push for cancer rehabilitation, there seems to
be no universal standard protocol among cancer
facilities for composing an exercise prescription.
In writing an exercise prescription, commonly
used assessments for establishing baselines for
post-rehabilitation comparisons are muscular
strength and endurance, balance, flexibility, and
cardiovascular endurance. Cardiovascular
exercises play a paramount role in a wellformulated exercise prescription, and
cardiovascular exercises can vary from clinic to
clinic. According to the National Academy of
Sports Medicine (2013), to develop a complete
program, the health and fitness professional must
assess the client, create a program with specific
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goals, and then apply a tool (such as a heart rate
measurement) to evaluate the client’s training
success. An accurate and proper exercise
prescription will produce improvements in aerobic
fitness, muscular strength, and overall QOL
(Ardic, 2014). In addition, exercise prescriptions
can potentially prevent some types of cancer and
reduce risk of cancer recurrence and cancerrelated death (Leiserowitz & Watchie, 2011).
For rehabilitation clinicians to make an
adequate program for a client, many initial tests
need to be performed, and cardiopulmonary
values are required. Blood lactate levels, percent
of oxygen saturation, and maximum volume of
oxygen consumption (VO2max) are
cardiopulmonary values factored into producing
an exercise prescription for a client. VO2max is
measured via a maximal cardiopulmonary test.
The value obtained from VO2max measures the
ability of the body to deliver oxygenated blood to
active skeletal muscle for ATP re-synthesis after
glycogen has been depleted from the active
muscle. A higher VO2max value indicates an
overall healthier individual. To measure a VO2max
value directly, a metabolic cart is necessary. The
metabolic cart has been deemed the gold standard
in determining VO2max, which uses gas analysis to
quantify the amount of oxygen consumed against
the amount of carbon dioxide produced. VO2max
tests requires an individual to exert themselves to
the point of exhaustion, having a respiration
exchange ratio (RER) of 1.15 or greater and blood
lactate greater than 8 mmol-1. VO2max tests are
generally designed for the presumed healthy
population, and do not typically cater to the
chronically diseased population. Factors such as
the expense of the equipment, the lack of trained
personnel, physical limitations, minimal
motivation, and persistent fatigue, may not make a
VO2max test feasible or valid for chronically
diseased populations (Jones, Haykowsky, Joy, &
Douglas, 2008; Pina & Karalis, 1990; Shackelford
et al., 2015; Stone, Lawlor, Nolan, & Kenny,
2011).
VO2peak can be defined as the highest level of
oxygen consumption achieved during a graded
treadmill test, regardless of whether maximum
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criteria are met (Heyward & Gibson, 2014).
VO2peak is often used as a cardiopulmonary value
for chronic diseased populations, such as CS, to
determine and evaluate one’s cardiopulmonary
system. It has been observed that there is no
significant variability in the values of VO2peak
compared to VO2max (Coquart et al., 2014; Jones
et al., 2011). Tests utilizing VO2peak are generally
used with chronic diseased populations because
VO2peak protocols are generally less taxing on the
participant and requires minimal equipment. In
fact, it has been observed that there are no
significant differences in final VO2 values
between a VO2peak and a VO2max test (Day,
Rossiter, Coats, Skasick, & Whipp, 2003;
Eldridge, Ramsey-Green, & Hossack, 1986;
Hawkins et al., 2006; Howley, 2007; Jones et al.,
2011).
There are numerous exercise protocols that
measure VO2peak directly or indirectly, such as the
Bruce treadmill protocol (BTP) (Pinkstaff et al.,
2011) and the Six Minute Walk Test (6MWT)
(Fuentes et al., 2014). The BTP has been deemed
a valid and accurate measurement of VO2peak
(Akinpelu et al., 2014). The BTP uses equations
from the American College of Sports Medicine’s
running and walking equations during the multistage treadmill protocol to estimate VO2peak
(American College of Sports Medicine, 2013;
Heyward & Gibson, 2014). Treadmill protocols,
such as the BTP, are more applicable for the
presumed healthy populations, such as athletes,
and do not cater to the specific needs of the
chronically diseased population. The BTP
increases in speed and incline very rapidly, and
for an individual to keep up with the demands of
the rigorous stages in the BTP, muscular strength
of the participant is also required. During these
intense treadmill protocol tests, CS may fatigue
quicker due to reasons other than cardiovascular,
or may have an increased risk of injuring
themselves trying to complete the protocol due to
the negative side effects of cancer and cancer
treatments. Research has shown up to 50% of
cancer patients suffer from cancer cachexia, a
progressive atrophy of adipose tissue and skeletal
muscle, resulting in weight loss, a reduced QOL,
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and a shortened survival time (Tisdale, 2009). The
degeneration of skeletal muscle can contribute to
the reason cancer survivors cannot advance far in
demanding treadmill protocols such as the BTP.
With the accumulation of cancer treatments
and the cancer itself, cancer survivors are less
likely to achieve accurate VO2peak values from
apparently healthy treadmill protocols. Protocols
such as the BTP, with greater increments in
magnitudes between stages, can result in an
overestimation of VO2peak, and show greater
variability (Bader, Maguire, & Balady, 1999;
Shackelford et al., 2015). Researchers have also
found that although the BTP is a valid way to
calculate VO2max in above average athletic
populations between 20 and 40 years of age, it
overestimates VO2max by 4 mL·kg-1·min-1 in
chronic diseased populations (Pollock, Foster,
Schmidt, Hellman, Linnerud, & Ward, 1982). It
stands to reason the BTP is not a suitable protocol
to estimate VO2peak in chronically diseased
populations, particularly in cancer survivors. On
the opposite end of the spectrum regarding
VO2peak protocols, there is the 6MWT. The
6MWT is one of the most familiar cardiovascular
tests used with chronic diseased populations
(cardiac and pulmonary) for VO2peak or with the
geriatric population for distance (American
Thoracic Society, 2012). Using the 6MWT with
regards to distance, is a prognostic value and is
effective to exhibit progress from prescribed
interventions. The 6MWT is utilized, owing to the
fact the protocol is very untroublesome,
inexpensive, and due to the belief that the geriatric
population, as well as the chronic diseased
populations cannot sustain higher intensities while
exercising. During the 6MWT, a participant walks
a designated hallway spanning a specified number
of meters, usually 100 meters, at any pace they
deem suitable for a six-minute period. The
participant may also dictate when he or she would
like to slow down and/or stop during the test. The
distance the participant ambulates in meters
during the six minutes is factored into equations
to determine VO2peak. However, the 6MWT has
been shown to greatly underestimate VO2peak.
Comparing VO2peak values derived from the
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6MWT and a portable metabolic cart, the 6MWT
underestimated VO2peak by 20% compared to a
metabolic cart (Faggiano et al., 1997). According
to Cahalin et al. (1996), the 6MWT is inferior to
other measures, such as bicycle ergometer
exercise testing, in predicting long- term survival
in cancer patients. An accurate measure of VO2peak
in creating a beneficial exercise prescription is
essential. Variability in overestimation and
underestimation of VO2peak can do potentially
more harm than good. Overtraining can cause
numerous changes in immunity that possibly
reflects physiological stress and immune
suppression (Gholamnezhad et al., 2014), while
undertraining can decrease an already inadequate
fitness level. As VO2peak also evaluates
cardiovascular abilities such as the intensity that
can be sustained, training at an inaccurate
intensity level can limit the benefits of
physiological responses to chronic resistance
training while following an exercise prescription
(Hickson et al., 1985).
Until recently, there was no standard way to
assess a cancer survivor’s VO2peak effectively
without the use of a metabolic cart. To alleviate
this problem, UNCCRI created a treadmill
protocol specific for cancer survivors. Unlike the
BTP, the UNCCRI treadmill protocol increases
intensity at a moderate and more manageable rate.
The gradual increases in magnitude allows not
only for a much safer cardiopulmonary endurance
test, but also allows cancer survivors to advance
further in the protocol to elicit a more accurate
VO2peak value. The correlation between the
UNCCRI treadmill protocol and a metabolic cart
in predicting VO2peak was very high (r = 0.93;
Shackelford et al. 2015). Literature has shown that
the UNCCRI treadmill protocol is the most
accurate treadmill test next to a metabolic cart in
determining VO2peak in cancer survivors
(Shackelford et al., 2015).
Compared to the widely used BTP which can
overestimate VO2peak, there has been minimal
research done on the accuracy of the 6MWT with
cancer survivors, which is hypothesized to
underestimate VO2peak. Submaximal VO2
prediction such as the 6MWT, are generally
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outperformed by peak workloads, like the
UNCCRI treadmill protocol. A submaximal VO2
is derived from steady-state exercise (Loe, Nes, &
Wisløff, 2016), whereas peak workloads are
obtained at the optimal amount of effort exhausted
at a given exercise bout. The 6MWT is prevalent
as a submaximal cardiopulmonary test to assess
the outcome measure in exercise rehabilitation
due to its simple nature (Alison et al., 2012). The
purpose of this present study was to determine the
validity of VO2peak obtained from the 6MWT
compared to the VO2peak obtained by the UNCCRI
treadmill protocol for cancer survivors. It was
hypothesized that the 6MWT would
underestimate VO2peak in cancer survivors, leading
to a lesser exercise intensity, which would further
substantiate the UNCCRI treadmill protocol as the
standard cardiopulmonary exercise protocol for
VO2peak in the cancer population.
METHOD
Participants
Participants for this study (N = 34) included
clients who were currently enrolled in UNCCRI’s
program. Participants met the following criteria:
(a) diagnosed with cancer, (b) at least 18 years of
age, (c) absence of severe cardiorespiratory
difficulties, such as chronic obstructive
pulmonary disease, (d) and or severe arterial
hypertension (resting systolic blood pressure >200
mmHg, resting diastolic blood pressure 110, or
both). Potential participants’ oncologists or
physicians faxed medical histories directly to
UNCCRI. All clients training at UNCCRI signed
an informed consent, agreeing to engage in
research for the institute upon entering the
program. Over the course of four months, all
clients of UNCCRI who entered the rehabilitation
program took part in this study; as well as clients
who were already training at UNCCRI and
wanted to participate in the study. Before
engaging in the study, a detailed explanation was
given on the protocols and what was expected
from the participant. Upon demonstrating they
understood the tasks being asked of them,
participants engaged in both the UNCCRI
treadmill protocol and the 6MWT during two of
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their upcoming training sessions. The protocols
used in this study had been approved by the
University of Northern Colorado’s Institutional
Review Board.
Procedures
Within a two-week period, the participants
either completed the 6MWT or the UNCCRI
treadmill protocol during week one, and then
completed the other protocol during the following
week. For the UNCCRI treadmill protocol, an
explanation stated that this was a test used to
measure VO2peak, and the participants should try
to reach their self-perceived maximum threshold
of fatigue; when they reached exhaustion, the test
was concluded. Participants were encouraged not
to use the handrails during the test, but if they did
choose to use the handrails, they would have to
grasp the handrails from the start of the protocol
to the termination of the protocol. Participants
were also informed that they would be asked their
Rating of Perceived Exertion (RPE) every three
minutes during the test. Additionally, a 3M™
Littmann® Classic II SE Stethoscope with
Prestige Medical Basics Sphygmomanometer Kit
was used on the participant’s arm to take blood
pressure every three minutes, a Clinical Guard ®
pulse oximeter was on the participant’s finger to
read oxygen saturation every minute, and a
Polar® heart rate monitor was strapped to each
participant’s chest to measure heart rate every
minute. Subsequently, once each patient reached
their perceived maximal exertion, a cool-down
period was administered to lower their vitals close
to resting measures. The test concluded when: (a)
participants could longer keep up with the demand
of work needed to keep up with the treadmill
protocol stage; (b) participants’ heart rate or
systolic blood pressure did not increase with
increased intensity; (c) diastolic blood pressure
varied more than 10 mmHg from resting
measures; (d) oxygen saturation dropped below
80%; and/or (e) participants felt the need to stop
due to any safety issues. Once participants
understood what was being asked of them, the test
began.
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The UNCCRI treadmill protocol required at
least three trained Cancer Exercise Specialists,
(CES) to be present during the test. A CES was
in charge of increasing the treadmill intensity
every minute to the appropriate speed and grade.
This same CES was in charge of using the
Clinical Guard ® pulse oximeter to record heart
rate and oxygen saturation. The second CES was
in charge of taking the client’s blood pressure on
the treadmill. The third CES was in charge of
spotting the participant, and observing any signs
of distress, indicators of safety and or health
problems. After the test concluded each
participant was given a guided cool-down.
During the cool-down, oxygen saturation and
heart rate were taken every minute. Every three
minutes during the cool-down period RPE and
blood pressure were also taken. Once the values
reached near resting measures, the treadmill was
stopped, and the test was terminated. A final
heart rate measurement was taken at the
conclusion of the test. VO2peak was calculated
using the American College of Sports Medicine's
running/walking equations: (a) the last stage the
cancer survivor successfully completed, (b) if the
individual was running or walking at the
termination of the protocol, (c) and if the
individual was holding onto the treadmill
handrails (Appendix B). The equations to derive
VO2peak by the UNCCRI treadmill protocol are as
follows:
•

Cancer survivor walking at the
termination point of the test without the
use of handrails:

VO2peak= (0.1 x S) + (1.8 x S x G) + 3.5
•

Cancer survivor walking and holding onto
the handrails at the termination of the test:

VO2peak = 0.694 [(0.1 x S) + (1.8 x S x G) +
3.5] + 3.33
•

Cancer survivor running at the termination
of test without the use of handrails:

VO2peak = (0.2 x S) + (0.9 x S x G) + 3.5
•

Cancer survivor running and holding onto
the handrails at the termination of the test:

https://digscholarship.unco.edu/urj/vol6/iss2/5

VO2peak =0.694 [(0.2 x S) + (0.9 x S x G) +
3.5] + 3.33
(S, Speed in meters/min; G, grade of treadmill
in %)
Alternatively, the 6MWT required very little
equipment. The 6MWT was conducted in a 12.6meter-long hallway at UNCCRI. There were two
chairs, one at both ends of the hallway, with a
cone placed one foot in front of each chair
indicating the end of the walkway. The
participants were told prior to the test that the goal
was to walk as far as possible in the six-minute
time period. If at any time participants felt the
need to stop and or sit down at any point during
the test they could do so at either end of the
hallway. Slightly different from the American
Thoracic Society (ATS) 6MWT protocol
guidelines, participants were notified at three
minutes that the test was half-way completed, and
at five minutes that there was only one-minute
remaining, opposed to being warned every minute
that had elapsed. During the test, verbal
encouragement was given, such as “Great Job.”
The participants were reminded they were able to
sit and rest when signs of distress appeared. Signs
of distress include excessive sweating, heavy
breathing, and dizziness. Once the six minutes
came to an end, the ambulated distance in meters,
rate pressure product (max heart rate* max
systolic blood pressure), final blood pressure, and
heart rate were measured using the Clinical Guard
® pulse oximeter and the Polar® heart rate
monitor were recorded. The forced expiratory
volume and forced vital capacity (volume/liters)
were measured by the MIR Spirolab III Portable
Desktop Spirometer®. Along with the forced vital
capacity and forced expiratory values, weight
(kg), height (cm), and other values were obtained
from the participants’ initial or reassessment using
the InBody770 ®. The 6MWT equations are as
follows:
•

Equation 1: VO2peak = 0.03 x distance (m)
+ 3.98

•

Equation 2: VO2peak = 0.02 x distance(m) –
0.191 x age(year) – 0.07 x weight(kg) +
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0.09 x height(cm) + 0.26 x RPP x 10-3 +
2.45
•

Equation 3: VO2peak = 0.02 x distance(m) 0.14 x age(year) – 0.07 x weight(kg) +
0.03 x height(cm) + 0.23 x RPP x 10-3 +
0.10 x FEV1 (L) – 1.19 x FVC (L) + 7.77

•

Equation 4: VO2peak = 4.948 + 0.023 *
distance (m)

(RPP, Rate Pulse Pressure; FVC, Forced vital
capacity; FEV1, Forced expiratory volume in
1 second) (see Appendix A).

collectively, while there was no significant
difference in diastolic blood pressure between the
two groups (p = 0.874). Figure 1 displays the
correlation (r = 0.86) between the VO2peak value
from the UNCCRI treadmill protocol and
equation three from the 6MWT. The average time
for a cancer survivors engaging in the UNCCRI
treadmill protocol was 10:45 (minutes, seconds),
while the average distance for the 6MWT was 485
meters.
Table 1. Mean differences of the 6MWT equations
compared to the UNCCRI treadmill protocol

Statistical Analysis
The VO2peak values from the four 6MWT
equations were compared to the UNCCRI
treadmill protocol VO2peak value by a repeated
measures ANOVA test using the IBM Statistical
Package for the Social Sciences 23. The repeated
measures ANOVA test examined any differences
in the 6MWT’s ability to determine VO2peak
compared to the UNCCRI treadmill protocol.
Paired T-tests were used to compare the
differences in mean systolic and diastolic blood
pressure values, and heart rate for the 6MWT
compared to the UNCCRI treadmill protocol.
Lastly, a Pearson –r correlation was used to see if
there was an appropriate correlation between
equation three from the 6MWT compared to the
UNCCRI treadmill protocol VO2peak. Equation
three was elected for the Pearson –r correlation by
virtue of possessing the most variables, eliciting
the most accurate and individualized VO2peak. The
significance for each of the analysis was set at p <
0.05.
RESULTS
Table 1 displays the mean significant
differences for VO2peak calculated using the four
6MWT equations against the UNCCRI treadmill
protocol. All 6MWT equations significantly
underestimated VO2peak compared to the UNCCRI
treadmill protocol (p < 0.001). Table 2 displays
the averages for heart rate, systolic and diastolic
blood pressure recorded during each protocol.
There was a significant difference in the heart rate
and systolic blood pressure between the 6MWT
and the UNCCRI treadmill protocol (p < 0.001)
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VO2Peak
(mL/kg-1/min-1)

Mean
Difference

p-value

(mL/kg-1/min-1)

UNCCRI
TP

24.4

Equation 1 18.3

6.2

<0.001

Equation 2 14.2

10.2

<0.001

Equation 3 8.5

15.9

<0.001

Equation 4 15.9

8.3

<0.001

Note: UNCCRI TP = University of Northern Colorado
Rehabilitation Institute Treadmill Protocol
Table 2. Average peak heart rate, systolic blood
pressure, and diastolic blood pressure of the UNCCRI
Treadmill Protocol compared to the 6MWT
UNCCRI
treadmill
protocol

6MWT

p-value

Avg. heart
rate (bpm)

150.6

111.9

<0.001

Peak
systolic
blood
pressure
(mmHg)

143.8

138.7

<0.001

Peak
diastolic
blood
pressure
(mmHg)

77.3

75.4

<0.874
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VO2PEAK VIA UNCCRI TM (ML/KG-1/MIN-1)

Figure 1. Correlation between the 6MWT equation 3 and UNCCRI treadmill protocol VO2peak values
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DISCUSSION
The present study examined the validity of the
6MWT compared to the standard UNCCRI
treadmill protocol in determining cancer
survivors' VO2peak. As hypothesized, the 6MWT
significantly underestimated VO2peak in cancer
survivors. This hypothesis was supported when
the mean difference between UNCCRI treadmill
protocol and equations 1, 2, 3, and 4 for the
6MWT had a significant mean difference (p <
0.001) compared to the UNCCRI treadmill
protocol. With the consistent underestimation of
VO2peak in each of the 6MWT equations, the
commonly used 6MWT does not appear to be a
reliable nor an accurate way to obtain VO2peak in
cancer survivors for the use in an exercise
prescription. Not only accuracy of the protocol,
but safety should also be an important
consideration in protocol choice, as it will affect
the efficacy and thereby the outcome measures of
the exercise program implemented (Kirkham,
Campbell, & Mckenzie, 2013). The UNCCRI
treadmill protocol was able to measure VO2peak in
the cancer survivors more accurately than the
6MWT. In addition to the significant
underestimated mean differences in all four

https://digscholarship.unco.edu/urj/vol6/iss2/5

20

25

30

35

40

45

VO2PEAK VIA 6MWT EQUATION 3 (ML/KG-1/MIN-1)

6MWT equations, the 6MWT produced a
significantly lower mean heart rate and mean
systolic blood pressure than the UNCCRI
treadmill protocol; the lower mean heart and mean
systolic blood pressure is an indicator of a lesser
intensity. Exercise intensity refers to the rate at
which activity is being performed and the required
amount of energy needed to sustain the particular
effort. The increase in heart rate and systolic
blood pressure during exercise is due to the
increased demand of oxygen by active muscles
throughout the body. The amount of oxygen
needed by the muscles is directly related to the
amount of oxygen consumed at a given moment.
Accordingly, the peak volume of oxygen being
consumed in the body establishes the intensity for
a structured and formulated exercise prescription.
The presence of intensity in a cancer rehabilitating
intervention requires precision in its application to
maximize its health benefits and to reduce risk of
adverse events in cancer survivors (Kirkham et
al., 2013).
Overall, clinicians utilize the 6MWT because
it is less strenuous on individuals who may have a
compromised cardiovascular system due to cancer
and cancer treatments. Previous literature has
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demonstrated that the UNCCRI treadmill protocol
is a safe and accurate protocol for cancer
survivors, and demonstrates cancer survivors can
perform more vigorous protocols to establish a
more valid VO2peak value (Shackelford et al.,
2015). Accurate VO2peak values for exercise
prescriptions are critical because the precise
intensity in which an individual exercises can
positively affect one's cardiovascular functions
which are indicative of overall health, QOL, and a
predictor of death. This study suggests the 6MWT
is an inaccurate way to obtain VO2peak, and
therefore clinicians should not use the 6MWT in
the cancer population. Instead, the UNCCRI
treadmill protocol should remain the standard
method of obtaining VO2peak in cancer
rehabilitation clinics and facilities.
Limitations and Future Directions
There were minimal limitations to this study.
First, the sample size was fairly small. Having a
larger number of participants could have
strengthened the significant difference between
the VO2peak values. In addition to the participant’s
enrollment at UNCCRI, many of the participants
had already partaken in the UNCCRI treadmill
protocol for assessments and reassessments for
the cancer rehabilitation program. Having being
familiarized to the UNCCRI treadmill protocol
could have primed the participants to do well in
the UNCCRI treadmill protocol. Adversely with
participants being unfamiliar with the 6MWT,
therefore not obtaining accurate results from the
6MWT protocol. The unfamiliarity of the
participants to the 6MWT did not seem to play a
contributing role in the results, but is a factor to
examine in the future. Lastly, one of the
limitations of the study was that the VO2peak from
the 6MWT was compared to the very accurate
VO2peak value from the UNCCRI treadmill
protocol and not compared to actual gas analysis.
Even though the UNCCRI treadmill protocol is
the most accurate treadmill protocol made
specifically for cancer survivors to get VO2peak
and was has a high correlation (r = 0.93) with gas
analysis, it does not elicit identical values to gas
analysis. For future studies, gas analysis needs to
be incorporated to have an indefinite value to
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compare VO2peak from the 6MWT to for absolute
accuracy.
For future research, a greater sample size is
suggested, and not only from participants who
currently train at UNCCRI. Having cancer
survivors who do not train at UNCCRI to also
partake in the UNCCRI treadmill protocol and the
6MWT would eliminate the experience factor,
thus generating the most accurate results.
Additionally, Dr. Larry Cahalin recommended
comparing a linear regression for the most
accurate 6MWT VO2peak value with the UNCCRI
treadmill protocol VO2peak value (L. Cahalin,
personal communication, March 31, 2016). The
mean underestimation of VO2peak by the 6MWT
could aid in making a correction equation for the
6MWT equations to be more valid way to obtain
VO2peak like the highly accurate UNCCRI
treadmill protocol.
CONCLUSION
The number of cancer survivors are
increasing, controversially are often left coping
with adverse side effects from both the cancer and
cancer treatments. Side effects related to cancer
and cancer treatments include fatigue, depression,
cachexia, decreased QOL, and, most commonly,
cardiovascular diseases. The plethora of negative
side effects that are coupled with cancer not only
effects one’s physical health, but their mental
health as well. Previous literature has
demonstrated cancer rehabilitation programs have
reversed and minimized the negative side effects
from cancer and cancer treatments (Spence et al.,
2010). Extremely effective cancer rehabilitation
programs use an individualized exercise
prescription to aid cancer survivors in returning to
their normal functioning capabilities pre-cancer
diagnosis. To have an effective exercise
prescription, accurate cardiopulmonary values
such as VO2peak are needed to train patients at a
precise intensity level to maximize the benefits
from chronic endurance training. Chronic
endurance training benefits the cardiopulmonary
system and ultimately improves overall QOL.
Based on the findings of the present study, the
6MWT is not an accurate/valid measure of
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VO2peak, which may limit physiological benefits.
Therefore, the treadmill protocol should remain
the standard. As a result of VO2peak values being a
critical component in exercise prescription and
intensity, inaccurate measures may limit the
physiological benefits of chronic exercise training
(Hickson et al., 1985). The UNCCRI treadmill
protocol should remain the standard protocol to
determine VO2peak in cancer survivors for the use
of an exercise prescription.
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